November 3, 2015 edition
maaf email atau password anda salah
Founded in 1948, Interbat is one of the country's top five pharmaceutical companies. It manufactures more than 270 pharmaceutical products, some of which are exported to Africa and other countries in Asia. Two months ago, Tempo came upon a document that triggered suspicions of Interbat paying doctors and hospitals in several regions to sell its drugs.
Interbat's CEO Noto Sukamto refused Tempo's request for an interview and instead referred us to the company's lawyer, Pieter Talaway. Talaway rejected all the allegations, claiming that Interbat was the victim of slander by some of the company's disgruntled employees. "There's plenty of unpleasant talk," he said at his Surabaya office two weeks ago.
Independent journalism needs public support. By subscribing to Tempo, you will contribute to our ongoing efforts to produce accurate, in-depth and reliable information. We believe that you and everyone else can make all the right decisions if you receive correct and complete information. For this reason, since its establishment on March 6, 1971, Tempo has been and will always be committed to hard-hitting investigative journalism. For the public and the Republic.